Skip to main content
. Author manuscript; available in PMC: 2013 Aug 22.
Published in final edited form as: Curr Pharm Des. 2011;17(31):3374–3380. doi: 10.2174/138161211798072562

Fig. (1).

Fig. (1)

Mitochondrial abnormalities are a common feature of both Alzheimer's disease and Parkinson's disease and thus may be a potential target for therapeutic intervention.